To further test the effect of ERRF on lapatinib sensitivity, we used two breast cancer cell lines that were ERBB2 positive and lapatinib sensitive [22, 46] and expressed higher levels of ERRF (Figure 1E), i.e., SK-BR-3 and BT-474. Here, SRARP is linked to breast cancer.